These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 579062)

  • 1. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.
    Ross SB; Ogren SO; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):337-52. PubMed ID: 579062
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical properties of 3,3-dimethyl-1-[3-(methylamino) propyl]-1-phenylindan HCl (LU 3-049) and selected tricyclic antidepressants.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):317-29. PubMed ID: 849078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
    Stancheva S; Grahovska T; Petkov VV
    Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methylmercury on brain biogenic amines in the developing rat pup.
    Taylor LL; DiStefano V
    Toxicol Appl Pharmacol; 1976 Dec; 38(3):489-97. PubMed ID: 13517
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat.
    Kueng W; Wirz-Justice A; Menzi R; Chappuis-Arndt E
    Neuroendocrinology; 1976; 21(4):289-96. PubMed ID: 1035790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acrylamide on biogenic amine levels, monoamine oxidase, and cathepsin D activity of rat brain.
    Dixit R; Husain R; Mukhtar H; Seth PK
    Environ Res; 1981 Oct; 26(1):168-73. PubMed ID: 7297529
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of copper loading on various tissue enzymes and brain monoamines in the rat.
    Lal S; Papeschi R; Duncan RJ; Sourkes TL
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):395-405. PubMed ID: 4851619
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.
    Venero JL; Machado A; Cano J
    Mech Ageing Dev; 1990 Dec; 56(3):253-63. PubMed ID: 2089199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of small doses of lead acetate on the concentration of biogenic amines].
    Levina EN; Chekunova MP; Minkina NA
    Farmakol Toksikol; 1973; 36(5):620-4. PubMed ID: 4788079
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine in aggressiveness.
    Valzelli L
    Adv Biochem Psychopharmacol; 1974; 11(0):255-63. PubMed ID: 4276860
    [No Abstract]   [Full Text] [Related]  

  • 18. Developmental characteristics of central monoamine neurons and their reciprocal relations.
    Jonsson G
    Exp Neurol; 1976 Dec; 53(3):801-14. PubMed ID: 1001399
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase activity measurements using radioactive substrates.
    Jain M; Sands F; Von Korff RW
    Anal Biochem; 1973 Apr; 52(2):542-54. PubMed ID: 4698849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.